Clinical Trial Update: Influenza Vaccination Strategy for Patients With Hematologic Malignancy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating an influenza vaccination strategy in patients with hematologic neoplasms; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Snippet

Sponsor: Asan Medical Center | Conditions: Hematologic Neoplasms, Influenza | Phase 3 | Status: RECRUITING